GSE repurchase risk is rippling through the MSR market housingwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from housingwire.com Daily Mail and Mail on Sunday newspapers.
Cereius, Inc., a biotechnology company developing therapies to treat cancer that has spread to the brain, has been acquired by San Diego-based Solve Therapeutics, Inc. (SolveTx).
A couple small deals with some unusual regional concentration also are in the market and one broker says many billions of dollars more are in the pipeline.
MSR trading volume this year is on pace to meet or exceed last year’s robust mark, when some $1 trillion in MSRs exchanged hands then fueled by the spike in interest rates. The trading volume of MSRs so far this year is on pace to meet or exceed last year’s robust mark, when some $1 trillion in MSRs exchanged hands then fueled by the spike in interest rates.
Rate volatility stemming from the banking crisis temporarily disrupted trading, but a broad range of deals large and small have gone up for bid since then.